<--- Back to Details
First PageDocument Content
Non-nucleoside reverse transcriptase inhibitors / Fixed dose combination / Pharmacology / Organofluorides / Cyclopropanes / Reverse-transcriptase inhibitor / Antiretroviral drug / Emtricitabine / Rilpivirine / Chemistry / Organic chemistry / Gilead Sciences
Date: 2013-11-01 12:25:00
Non-nucleoside reverse transcriptase inhibitors
Fixed dose combination
Pharmacology
Organofluorides
Cyclopropanes
Reverse-transcriptase inhibitor
Antiretroviral drug
Emtricitabine
Rilpivirine
Chemistry
Organic chemistry
Gilead Sciences

Government of the District of Columbia Department of Health AIDS Drugs Assistance Program (ADAP): FORMULARY The following drugs are available through the District of Columbia AIDS Drug Assistance Program. HIV/AIDS DRUGS:

Add to Reading List

Source URL: doh.dc.gov

Download Document from Source Website

File Size: 156,49 KB

Share Document on Facebook

Similar Documents

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

Microsoft WordDOCX

Microsoft WordDOCX

DocID: 1rnqZ - View Document

Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

DocID: 1rinj - View Document

SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1  SECTION 1

SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1

DocID: 1rdYu - View Document

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib

DocID: 1rdbp - View Document